News

 

 

Funding: New Awards

Marc Ernstoff, MD
Member, Immunology and Cancer Immunotherapy Research Program at Norris Cotton Cancer Center and Professor of Medicine at Dartmouth Medical School

  • Prometheus Laboratories Inc./Sub with Dana-Farber
    The High-Dose Aldesleukin (IL-2) 'Select' Trial: A Prospective Tissue Collection Protocol to Investigate Predictove Models of Response to High Dose IL-2 Treatment in Patients with Advanced Melanoma

Gary Schwartz, MD
Member, Molecular Therapeutics Research Program at Norris Cotton Cancer Center and Associate Professor of Medicine at Dartmouth Medical School

  • ECOG
    A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer